Antion Biosciences SA

We are very happy to announce that Marco Alessandrini, our CEO, Antonija Šakić, our Head of R&D, and Audrey Roussel-Gervais, our Head of Clinical Development, will be representing Antion Biosciences at the Momentum in Cell and Gene Therapy Symposium tomorrow, June 19, 2024, organized by SK pharmteco. The Momentum in Cell and Gene Therapy Symposium is a premier gathering for leaders and innovators in the field of cell and gene therapy. If you are attending the symposium and would like to connect with Marco, Antonija, or Audrey, please do not hesitate to reach out. We look forward to engaging conversations and exciting new opportunities! #CellAndGeneTherapy #Innovation #AntionBio #R&D #ClinicalDevelopment #MomentumSymposium #SKPharmteco

We are thrilled to announce that Antonija Šakić, our Head of R&D at Antion Biosciences SA, will be attending the Bio International Convention in San Diego from 3-6 June, 2024. Antion is in active partnering and capital raise mode, so please feel free to contact Antonija to schedule a meeting through the BIO platform or reach out directly via LinkedIn.   You can set up a meeting with Antonija Šakić to discuss our multiplex engineering platform and how we are applying it to develop a best-in-class solution for the treatment and potential cure of B-cell driven autoimmune diseases. Don't miss the opportunity to learn more about our groundbreaking work! We look forward to connecting and exploring new opportunities!   #Bio2024 #Biotech #antionbio #R&D #Innovation #Partnering #Investment #Networking #AutoimmuneDisease #MultiplexEngineering

We are thrilled to announce our participation in ISCT 2024, starting tomorrow, from May 29 to June 1! 🌟 Join us as our Head of Clinical Development, Audrey Roussel-Gervais, presents our groundbreaking research on "Multiplex Silencing of Six Targets for Engineering of Next Generation, 'Off-the-Shelf' CAR T-cells." 📅 You can catch Audrey's poster presentation (#993) at two key events: 1️⃣ Welcome Reception & Poster Networking Reception 1 🗓️ Wednesday, May 29, 2024 🕖 07:00 PM - 08:30 PM PDT 📍 Exhibit & Poster Hall 2️⃣ Poster Networking Reception 2 🗓️ Thursday, May 30, 2024 🕕 06:00 PM - 07:30 PM PDT 📍 Exhibit & Poster Hall Don't miss this opportunity to connect with Audrey and learn more about our innovative approach to CAR T-cell engineering. See you in Vancouver! 🌐✨ #ISCT2024 #Antionbio #CARTCells #Biotech #Innovation #ClinicalDevelopment #NextGenTherapies"

🌟 Join us at BioEquity Europe 2024 in San Sebastián, Spain! 🌟 We are very happy to announce our participation at BioEquity Europe, happening next week from 12-14 May. Our CEO, Marco Alessandrini, and CFO, Gérald Thomé, will be present and ready to engage with fellow industry leaders. Join us for the Antion Biosciences SA presentation, where Marco will highlight the unique properties of our multiplex engineering platform and how we are applying it to develop a best-in-class solution for the treatment and potential cure of B-cell driven autoimmune disease. 🏛 Location: Room 4+5 📅 Date: Tuesday, May 14th, 2024 🕒 Time: 14h50 - 14h59 #bioequity #cellandgenetherapy #autoimmunedisease #Antionbio #InnovationsInScience #Biotech #Healthcare

🌟 Join us at Swiss Biotech Day 2024 in Basel, Switzerland! 🌟 We're thrilled to announce that Marco Alessandrini, Audrey Roussel-Gervais, Antonija Šakić and Gérald Thomé will all be present at Swiss Biotech Day from April 22nd to 23rd. Don't miss our company presentation in the Singapore Room on Monday, April 22nd from 3:00 PM to 3:15 PM. Additionally, come explore our poster presentation (poster no. 7) located in Hall 4.1 on the 1st floor. It's a prime opportunity to dive into our promising therapeutic pipeline and engage in discussions about recent developments at Antion. 🚀 Exciting News: We're also a proud sponsor of the panel session on "Recent developments and future avenues in Cell and Gene Therapy" from 09:00 to 09:45 on Tuesday, April 23rd. We're keen to connect with investors, industry peers, and stakeholders at this prestigious event. Join us to explore investment and partnering opportunities, and to discuss the future of biotech innovation. 📍 Swiss Biotech Day 2024 📅 Date: April 22nd-23rd, 2024 🏛 Venue: Basel, Switzerland #SwissBiotechDay #Antionbio #ScientificInnovations #BioTech #Healthcare 🧬

🌟 Join us at the 2024 Cell & Gene Meeting on the Med in Roma, Italy! 🌟   We are thrilled to be part of the 2024 Cell & Gene Meeting on the Med, happening next week from April 9th to 11th. Our CEO, Marco Alessandrini, will be present, ready to engage with fellow industry leaders, reveal exciting new data, and discuss the broadening of our therapeutic pipeline.   🏛 Salone Dei Cavalieri, Section 2 📅 Date: Thursday, April 11th, 2024 🕒 Time: 09:45 - 10:00am   We invite you to join us as Marco Alessandrini explores the latest advancements and opportunities shaping our industry. Let's connect and pave the way for a brighter future together! See you there! 🌐   #CGMed24 #cellandgenetherapy #Antionbio #InnovationsInScience #Biotech #Healthcare

Today kicks off our participation at Bio-Europe Spring in Barcelona, Spain, from March 18th to 20th. Join us as our CEO, Marco Alessandrini, presents insights about our company. 🌐 📍 Presentation: Room 133/134 🗓 Monday, 18 March 2024 🕒 16:15 - 16:30 You can also find us at the Swiss Biotech Association Pavilion: 📍 Booth 85, Level 0 🗓 18 - 20 March 2024 We welcome you to stop by and say hello! See you there! #BioEuropeSpring #AntionBio #Biotech #Healthcare

🎉 Exciting News from Antion Biosciences! 🎉 We are thrilled to share groundbreaking developments, marking a pivotal moment in the advancement of our technology platform. In a press release dated March 6th, 2024, Antion announced remarkable progress in two key areas: 1️⃣ Release of in vivo Proof-of-Concept data: Excellent efficacy of it’s lead therapeutic candidate, “miCAR7”, in an aggressive model of tumor-engrafted mice. Antion’s miCAR7 is an allogeneic, next generation CAR T-cell therapy for treatment of CD7 postive malignancies. “miCAR7 is the product of thoughtful design and remarkable engineering, considering the simultaneous and highly efficient modulation of six molecules”, commented Dr. Marco Alessandrini, CEO of Antion. This compelling data, which we unveiled for the first time at the 7th CAR-TCR Summit Europe in London on February 28th, confirms that our technology can be implemented within a product that potently eradicates tumor cells. 2️⃣ Milestone in a Strategic Partnership: Antion achieved an important milestone in its collaboration with Allogene Therapeutics. Our successful delivery of novel gene constructs for silencing 4 relevant targets underscores the exceptional capability of our multiplex gene silencing platform. Dr. Zachary J Roberts MD PhD, Executive Vice President, Research & Development, and Chief Medical Officer of Allogene, commented “The achievement of this milestone reflects the successful outcome and reinforces our confidence in Antion’s technology.” These milestones set the stage for Antion's future endeavors. With a validated technology platform, established operations, and fruitful collaborations, we are now perfectly poised to accelerate pipeline developments and forge strategic partnerships with global innovation leaders. Join us in celebrating these achievements as we continue our journey towards revolutionizing cell and gene therapy to benefit patients the world over. #Antionbio #GeneTherapy #CellTherapy #Immunotherapy #Oncology #CGT #Allogene #CARTCR #Innovation #Science #Healthcare #PressRelease

🚀 Don't Miss Out! 🚀 Today, our CEO, Marco Alessandrini, is gearing up for an unforgettable moment at the CAR-TCR Summit in London! 🎉 Get ready to witness the unveiling of our game-changing data featuring miCAR7, Antion's lead therapeutic candidate targeting CD7-positive malignancies. 💥 This next-generation CAR T-cell showcases the implementation of our technology platform to multiplex-engineer allogeneic, hypoimmunogenic, and fratricide-resistant anti-CD7 CAR T-cells—all from a single gene construct, and in a single engineering step. 🧬 Join us at the CAR-TCR Summit on February 28th at 14h45 to see firsthand the groundbreaking advancements our team has achieved. 🕑 A big shout-out to the organizers and ScaleReady for facilitating this incredible opportunity! 🙌 #CAR_TCRSummit #AntionBio #Innovation #CancerResearch

🌟 Celebrating International Day of Women and Girls in Science! 🌟 This weekend, we honor the remarkable achievements of women in science and acknowledge the crucial role they play in shaping our world. From groundbreaking discoveries to innovative research, their contributions know no bounds. Yet, while we celebrate their achievements, it's important to recognize the ongoing need for gender equality in science and society. We should strive to break down all barriers and create opportunities for all to pursue their passion for science, regardless of gender. To all the incredible women of Antion Biosciences SA, your dedication, passion, and expertise drive our company forward every day. Thank you for your invaluable contributions to our scientific endeavors and for inspiring future generations of scientists. Together, we will continue to #BreakTheBias and create a more inclusive and equitable scientific community. Happy International Day of Women and Girls in Science! 💫 🔬 #WomenInScience #GenderEquality #Antionbio